Geneos Wealth Management Inc. Gsk PLC Transaction History

Geneos Wealth Management Inc.

$2.6 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$42.05 - $47.77 $12,110 - $13,757	288 Added 1.06%	27,513 $1.22 Million
Q1 2022 May 16, 2022	SELL	$40.23 - $47.74 $10,459 - $12,412	-260 Reduced 0.95%	27,225 $1.19 Million
Q4 2021 Feb 09, 2022	SELL	$38.88 - $45.31 $8,359 - $9,741	-215 Reduced 0.78%	27,485 $1.21 Million
Q3 2021 Nov 09, 2021	BUY	$38.79 - $43.16 $8,688 - $9,667	224 Added 0.82%	27,700 $1.06 Million
Q2 2021 Jul 08, 2021	SELL	$36.52 - $41.46 $73,733 - $83,707	-2,019 Reduced 6.85%	27,476 $1.11 Million
Q1 2021 Jun 17, 2021	BUY	$34.27 - $40.01 $55,071 - $64,296	1,607 Added 5.76%	29,495 $1.1 Million
Q4 2020 May 19, 2021	BUY	$34.07 - $39.94 $43,132 - $50,564	1,266 Added 4.76%	27,888 $996,000
Q3 2020 Sep 07, 2021	SELL	$38.11 - $42.99 $50,686 - $57,176	-1,330 Reduced 4.76%	26,622 $1.01 Million
Q2 2020 Sep 07, 2021	BUY	$37.87 - $43.58 $419,523 - $482,779	11,078 Added 65.65%	27,952 $1.13 Million
Q1 2020 Sep 07, 2021	SELL	$32.47 - $48.83 $29,223 - $43,947	-900 Reduced 5.06%	16,874 $614,000
Q4 2019 Sep 07, 2021	BUY	$42.0 - $48.25 $1,848 - $2,123	44 Added 0.25%	17,774 $840,000
Q3 2019 Sep 07, 2021	BUY	$40.46 - $43.52 $13,554 - $14,579	335 Added 1.93%	17,730 $750,000
Q2 2019 Sep 07, 2021	SELL	$39.4 - $42.7 $9,889 - $10,717	-251 Reduced 1.42%	17,395 $696,000
Q1 2019 Sep 07, 2021	BUY	$38.57 - $42.69 $21,213 - $23,479	550 Added 3.22%	17,646 $737,000
Q4 2018 Sep 07, 2021	BUY	$37.8 - $42.69 $134,076 - $151,421	3,547 Added 26.18%	17,096 $652,000
Q3 2018 Sep 07, 2021	BUY	$39.75 - $42.69 $75,008 - $80,556	1,887 Added 16.18%	13,549 $544,000
Q2 2018 Sep 07, 2021	BUY	$39.61 - $42.76 $8,714 - $9,407	220 Added 1.92%	11,662 $470,000
Q1 2018 Sep 07, 2021	SELL	$36.18 - $40.15 $11,867 - $13,169	-328 Reduced 2.79%	11,442 $447,000
Q4 2017 Sep 07, 2021	SELL	$35.34 - $41.9 $16,786 - $19,902	-475 Reduced 3.88%	11,770 $417,000
Q3 2017 Sep 07, 2021	SELL	$39.44 - $41.55 $9,307 - $9,805	-236 Reduced 1.89%	12,245 $497,000
Q2 2017 Sep 07, 2021	SELL	N/A	-71 Reduced 0.57%	12,481 $538,000
Q1 2017 Sep 07, 2021	SELL	N/A	-5,717 Reduced 31.29%	12,552 $529,000
Q4 2016 Sep 07, 2021	BUY	N/A	11,079 Added 154.09%	18,269 $703,000
Q3 2016 Sep 07, 2021	BUY	N/A	829 Added 13.03%	7,190 $310,000
Q2 2016 Sep 07, 2021	SELL	N/A	-1,685 Reduced 20.94%	6,361 $274,000
Q1 2016 Sep 07, 2021	BUY	N/A	8,046	8,046 $324,000

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.

Account